Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Thiourea compounds

A compound, thiourea technology, applied in the preparation of organic compounds, active ingredients of heterocyclic compounds, organic chemistry, etc., can solve problems such as low success rate, high price, and low patient acceptance

Inactive Publication Date: 2009-09-02
NAT INST OF HEALTH REPRESENTED BY THE SEC OF THE DEPT OF HEALTH & HUMAN SERVICES NAT INST OF HEALTH
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, the success rate of treatment with interferon alpha is not high, especially for genotype-I infections that mainly occur in Europe, Japan and the United States
And expensive, low patient acceptance

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Thiourea compounds
  • Thiourea compounds
  • Thiourea compounds

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0083] Example 1, preparation of compound 1: 1-(3-(5-phenylpentyloxy)phenyl)thiourea (1-(3-(5-phenylpentyloxy)phenyl)thiourea)

[0084]

[0085] First, 1.2 g of potassium carbonate (8.7 mmol) was added to a stirred mixture consisting of 0.8 g of 3-nitrophenol (5.8 mmol), 1.32 g of (5-bromo-pentyl)-benzene (5.8 mmol), 0.96 g of potassium iodide (5.8 mmol) and 15 ml of N-methylpyrrolidone in a suspension. The above mixture was stirred at 90°C for 4 hours. After the reaction mixture was cooled to room temperature, 30 mL of water was added to terminate the reaction, and then extracted with ethyl acetate (30 mL×3). The combined organic phases were washed with brine and concentrated under vacuum. After the obtained residue was subjected to silica gel column chromatography, 1.4 g of 1-nitro-3-(5-phenylpentyloxy)benzene (4.93 mmol, yield 85%) was obtained as a colorless oil.

[0086] 5.57 g of tin(II) chloride (24.7 mmol) was added to a solution consisting of 1.4 g of 1-nitro-3-...

Embodiment 2

[0088] Example 2, preparation of compound 2: 1-(3-(4-phenylbutoxy)phenyl)thiourea (1-(3-(4-phenylbutoxy)phenyl)thiourea)

[0089] Its preparation method is similar to Example 1. EI-MS (M+1): 301

Embodiment 3

[0090] Example 3, preparation of compound 3: 1-(3-(3-phenylpropoxy)phenyl)thiourea (1-(3-(3-phenylpropoxy)phenyl)thiourea)

[0091] Its preparation method is similar to Example 1. EI-MS (M+1): 287

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

This invention relates to thiourea compounds described herein. These thiourea compounds can be used to treat hepatitis C virus infection.

Description

[0001] cross reference [0002] Pursuant to 35 U.S.C. §119(e), this application claims priority to US Provisional Application 60 / 837,782, filed August 15, 2006. The content of this provisional application is hereby incorporated by reference. Background technique [0003] Hepatitis C virus (HCV) infection is estimated to affect 170 million people worldwide. The disease is mainly spread through contaminated blood products. Although the spread of the disease has slowed due to advances in blood screening mechanisms in many countries, HCV infection remains the leading cause of death from liver-related disease worldwide. For example, approximately 10,000 people die each year from hepatitis C virus infection in the United States alone. Due to the lack of effective treatment, this mortality rate is projected to more than triple in the ensuing two decades. [0004] At present, the success rate of treatment with interferon alpha is not high, especially for genotype-I infections that...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/145A61K31/24A61K31/341A61K31/381A61K31/40A61K31/404A61K31/44A61K31/451A61K31/47A61K31/495A61K31/54A61K31/5375A61P31/12C07C335/18C07C335/20C07D207/09C07D207/327C07D209/04C07D213/63C07D215/20C07D215/233C07D217/02C07D241/04C07D279/12C07D295/14C07D295/155C07D307/54C07D333/28
CPCC07D209/82C07D215/233C07D213/74C07D217/24C07D295/135C07D307/42C07D233/60C07D215/26C07D233/42C07D307/91C07C335/20C07D333/16C07D217/04C07C335/16C07D239/34C07C2101/14C07C335/18C07C2103/18A61P31/12A61P31/16C07C2601/14C07C2603/18
Inventor 陈志豪徐祖安康祐竣李忠吉李彦俊赵宇生王丽雯
Owner NAT INST OF HEALTH REPRESENTED BY THE SEC OF THE DEPT OF HEALTH & HUMAN SERVICES NAT INST OF HEALTH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com